Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Gelmedic AB
AB
Active
Org 5565638615
Bondevägen 5, 237 32
Bjärred
General medical practice activities
·
NACE 8621
Est. 1998 · 27 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Gelmedic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
5M
4M
2M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 3M (+50% vs 2023)
3M
+50%
2024
2025: 4M (+33% vs 2024)
4M
+33%
2025
EBITDA
SEK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 2M
2M
2024
2025: 2M (0% vs 2024)
2M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
3 829
3 325
2 007
2 270
1 652
Staff expenses
−1 227
−1 207
−1 466
−970
—
EBITDA
2 065
1 818
389
1 112
916
Depreciation & amort.
−160
−135
−114
−2
−2
EBIT
1 905
1 684
275
1 109
914
Net financials
3
11
9
−24
—
Profit before tax
1 396
1 279
623
683
689
Tax
−299
−267
−133
−149
−156
Net profit
1 097
1 012
490
534
533
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
3 747
2 488
1 661
2 862
1 756
Equity
1 832
1 135
783
1 493
1 159
Long-term debt
—
—
—
—
0
Short-term debt
699
650
590
741
372
Total debt
699
650
590
741
372
Financial ratios
5-year trend
EBITDA margin
53,9 %
This company
15,8 %
Market median
This company
Market median
241% above market
2021
2025
Equity ratio
48,9 %
This company
38,2 %
Market median
This company
Market median
28% above market
2021
2025
Return on equity
59,9 %
This company
18,4 %
Market median
This company
Market median
226% above market
2021
2025
Net profit margin
28,6 %
This company
8,1 %
Market median
This company
Market median
253% above market
2021
2025
Asset turnover
1,02×
This company
1,12×
Market median
This company
Market median
9% below market
2021
2025
Debt / equity
1,05×
This company
0,62×
Market median
This company
Market median
69% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Gelmedic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
